Cinema8
20.2.2024 15:04:14 CET | ACCESS Newswire | Press release
CAMBRIDGE, ENGLAND / ACCESSWIRE / February 20, 2024 / Cinema8, the innovative AI-core video experience platform, is thrilled to announce a strategic partnership with Dailymotion, a leader in video solution services. The partnership is set to revolutionise the digital media industry by adding interactivity to videos on Dailymotion's cutting-edge video technology.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Cinema8 has been at the forefront of redefining video engagement, specialising in transforming passive viewing into dynamic, interactive experiences. The platform offers a diverse range of tools to enhance viewer engagement through its AI-core technology. Features like AI-generated subtitles with translations in over 100 languages, automating video management tasks like SEO-compatible video summarisation, and innovative interactivity options with over 1,000 ready-to-use widgets position Cinema8 as a key player in the digital video strategy domain.
This collaboration is expected to bring a wealth of benefits to both Dailymotion and Cinema8. By partnering with Cinema8, Dailymotion can offer interactive video player enabling enterprises to maximize their return on investment and reach their engagement goals, particularly in e-learning, video marketing, and corporate communications. Cinema8's array of interactive features, such as gamification, personalization, and shoppable elements, as well as its video creation tools like screen recording and video editing, will now be available to a broader customer through Dailymotion.
Mr. Alisan Erdemli, CEO of Cinema8, expresses his enthusiasm about the partnership: "With our recent partnership and integration features, we're excited to bring the limitless engagement power of interactive videos to Dailymotion customers. Interactive experiences are the future of viewing, and I'm looking forward to making streaming smarter a success with Dailymotion."
Remi Leclancher, VP Partnerships in EMEA at Dailymotion commented on the partnership, "This collaboration with Cinema8 represents a significant step in our ongoing effort to enhance the digital video experience for our customers. Cinema8's innovative approach to interactive content aligns with our vision of helping enterprises achieve their goals through cutting-edge video solutions."
Cinema8 and Dailymotion both remain committed to pushing the boundaries of digital video solutions. This partnership not only symbolises a key development for both organisations but also heralds a new era of interactive video content, promising to redefine viewer engagement in the digital age.
Find out more about our interactive video solutions.
Contact us for more information.
Contact Information:
Cinema8 Media Relations
Contact Name: Rosan Erdemli
Phone Number: +44 20 3318 6011
Email Address: info@cinema8.com
Website: https://cinema8.com/
Follow us on
https://www.linkedin.com/company/cinema8/
https://twitter.com/cinema8official
https://www.facebook.com/Cinema8official
https://www.instagram.com/cinema8.official/
https://www.youtube.com/c/Cinema8official
SOURCE: Cinema8
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom